Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Danaher and other ETFs, options, and stocks.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
63,000
Employees63,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
63,000
Employees63,000

DHR Key Statistics

Market cap
196.90B
Market cap196.90B
Price-Earnings ratio
45.06
Price-Earnings ratio45.06
Dividend yield
0.40%
Dividend yield0.40%
Average volume
2.21M
Average volume2.21M
High today
$265.94
High today$265.94
Low today
$263.20
Low today$263.20
Open price
$264.75
Open price$264.75
Volume
2.96M
Volume2.96M
52 Week high
$265.94
52 Week high$265.94
52 Week low
$182.09
52 Week low$182.09

DHR News

Yahoo Finance 2d
Insider Sale: President & CEO Rainer Blair Sells 9005 Shares of Danaher Corp - Yahoo Finance

On May 16, 2024, Rainer Blair, President & CEO of Danaher Corp (NYSE:DHR), executed a sale of 9,005 shares of the company. The transaction was filed on the same...

Insider Sale: President & CEO Rainer Blair Sells 9005 Shares of Danaher Corp - Yahoo Finance
CNBC 5d
Danaher's rally shows how sticking with a troubled stock of a good company can pay off - CNBC

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on W...

Danaher's rally shows how sticking with a troubled stock of a good company can pay off - CNBC
Yahoo Finance 5d
Danaher Rides on Business Strength Amid Headwinds - Yahoo Finance

Danaher Corporation DHR has been benefiting from strength in its Life Sciences segment, driven by stable demand in the academic and applied markets, and strong...

Danaher Rides on Business Strength Amid Headwinds - Yahoo Finance

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
26.9%
Sell
0%

More DHR News

Yahoo Finance 5d
Danaher Corp: An Exploration into Its Intrinsic Value - Yahoo Finance

In this article, we will take a look into Danaher Corp's (NYSE:DHR) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead...

Danaher Corp: An Exploration into Its Intrinsic Value - Yahoo Finance
Benzinga 6d
Major Decision: Matthew McGrew Exercises Options, Realizing $4.89M At Danaher - Danaher - Benzinga

Loading... Loading... A substantial insider activity was disclosed on May 13, as McGrew, EVP & Chief Financial Officer at Danaher DHR, reported the exercise of...

Major Decision: Matthew McGrew Exercises Options, Realizing $4.89M At Danaher - Danaher - Benzinga
Yahoo Finance 7d
Global Molecular Cytogenetics Market Outlook 2024-2028: Roche, Danaher, and Agilent Technologies Lead Molecular ... - Yahoo Finance

Company Logo Global Molecular Cytogenetics Market Global Molecular Cytogenetics Market Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global Molecular Cytogen...

Global Molecular Cytogenetics Market Outlook 2024-2028: Roche, Danaher, and Agilent Technologies Lead Molecular ... - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.